GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

VG-3927   Click here for help

GtoPdb Ligand ID: 14242

Synonyms: VG3927
Compound class: Synthetic organic
Comment: VG-3927 (Vigil Neuroscience) is an orally available TREM2 agonist [2]. It is proposed to increase the neuroprotective functions of microglia, as a mechanism to combat Alzheimer's disease-driven brain pathologies.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 61.91
Molecular weight 451.92
XLogP 1.93
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=NC2=CC(=NC(=C2N=C1C)C3=C(C=C(C=C3)Cl)F)[C@H]4CCO[C@H](C4)C5=CN(C)N=C5
Isomeric SMILES CN1C=C(C=N1)[C@H]2C[C@H](CCO2)C3=NC(C4=CC=C(Cl)C=C4F)=C5N=C(C)C(C)=NC5=C3
InChI InChI=1S/C24H23ClFN5O/c1-13-14(2)29-24-21(28-13)10-20(30-23(24)18-5-4-17(25)9-19(18)26)15-6-7-32-22(8-15)16-11-27-31(3)12-16/h4-5,9-12,15,22H,6-8H2,1-3H3/t15-,22+/m0/s1
InChI Key DGBQOJDFECEEKU-OYHNWAKOSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
VG-3927 is proposed as an Alzheimer's disease therapeutic. A phase 1 study has been completed.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT06343636 A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease Phase 1 Interventional Vigil Neuroscience, Inc.